CP
MIRM icon

CenterBook Partners’s Mirum Pharmaceuticals MIRM Stock Holding History

CenterBook Partners’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,702
Closed -$1.82M – 802
2026
Q1 		$1.82M Sell
19,702
-25,665
-57% -$2.41M 0.1% 252
2025
Q4 		$3.58M Buy
45,367
+37,010
+443% +$2.66M 0.18% 165
2025
Q3 		$613K Buy
+8,357
New +$531K 0.03% 442
2024
Q4 		– Sell
-11,530
Closed -$450K – 548
2024
Q3 		$450K Sell
11,530
-23,355
-67% -$932K 0.03% 399
2024
Q2 		$1.19M Sell
34,885
-87,572
-72% -$2.3M 0.07% 319
2024
Q1 		$3.08M Buy
122,457
+70,620
+136% +$1.94M 0.21% 179
2023
Q4 		$1.53M Buy
51,837
+36,699
+242% +$1.11M 0.19% 183
2023
Q3 		$478K Sell
15,138
-12,984
-46% -$356K 0.06% 338
2023
Q2 		$728K Sell
28,122
-26,231
-48% -$698K 0.09% 284
2023
Q1 		$1.31M Sell
54,353
-111
-0.2% -$2.53K 0.18% 179
2022
Q4 		$1.06M Buy
+54,464
New +$1.08M 0.17% 189
2022
Q3 		– Sell
-14,659
Closed -$285K – 424
2022
Q2 		$285K Sell
14,659
-3,737
-20% -$88.1K 0.06% 332
2022
Q1 		$405K Buy
18,396
+1,651
+10% +$33.7K 0.14% 237
2021
Q4 		$267K Buy
+16,745
New +$260K 0.16% 218

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CenterBook Partners's MIRM Position: Q2 2026 in Review

CenterBook Partners sold out of Mirum Pharmaceuticals (MIRM) in Q2 2026, closing a stake of 19,702 shares — an estimated $1.82M sold.

CenterBook Partners first reported a position in MIRM in Q4 2021 and held it in 14 quarters. The position peaked at $3.58M in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • CenterBook Partners reported no remaining Mirum Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • CenterBook Partners sold 19,702 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.82M.
  • CenterBook Partners first reported a position in Mirum Pharmaceuticals in Q4 2021 and held it in 14 quarters.
  • CenterBook Partners's Mirum Pharmaceuticals position peaked at $3.58M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on CenterBook Partners's 13F filing for Q2 2026, filed 11 Aug 2026.